イノベーションハブ
創薬のライフサイクルにおけるあらゆる段階の最新のブレイクスルー、技術、リソースをご紹介します。
Button Text





Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Cell Culture & Characterization
Disease Models
In Vitro Assays
Toxicology
PromoCell
Antibodies
Protein Sciences
Cell Culture & Characterization
In Vitro Assays
Biointron
Protein Sciences
Cocoon Bioscience

ブログ
Evolving Secondary Pharmacology: Functional, Dose-Response Safety Panels For Every Stage Of Discovery
9月 22, 2025
スポンサー:
スポンサー
ブログを読む
Pharmacology
In Vitro Assays
Discovery Chemistry
Toxicology
ICE Bioscience
In Vitro Assays
Bioimaging
Protein Sciences
Cell Culture & Characterization
Toxicology
No items found.

ブログ
Tumor Tissue Microarrays (TMAs): A High-Throughput Engine for Cancer Research
9月 17, 2025
スポンサー:
スポンサー
ブログを読む
Biomarkers
Disease Models
Bioimaging
Protein Sciences
DNA & RNA
Crown Bioscience
Antibodies
Protein Sciences
In Vitro Assays
Specifica
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.

ブログ
The Role of Recombinant Antibody Platforms in Advancing Therapeutic Development: Key Insights and Considerations for Production Success
8月 21, 2025
スポンサー:
スポンサー
ブログを読む
Antibodies
Protein Sciences
Cell Culture & Characterization
In Vitro Assays
Biointron
Protein Sciences
No items found.

ブログ
Bridging the Gap: Image Software Quantification vs. Pathologist Scoring in Histopathology
7月 23, 2025
スポンサー:
スポンサー
ブログを読む
No items found.
Applied Pathology Systems

ブログ
Differentiating Between CROs, CDMOs and CMOs: How Each Plays a Role in Drug Development
7月 2, 2025
ブログを読む
Clinical Trials
Pharmacology
No items found.
Disease Models
Eliala Alice Salvadori
Jason Rogers
Noldus Information Technology
No items found.
Health Economics & Outcomes Research (HEOR)
Danielle Drachmann
Josie Godfrey
Kristine Sørensen
Beth Lesher
Kelly McCarrier
OPEN Health
HealthEconomics.com
Disease Models
DNA & RNA
Cell Culture & Characterization
Eduardo Marbán
No items found.
American Physiological Society
European Council for Cardiovascular Research
Disease Models
Bradley Palmer
IonOptix
American Physiological Society
European Council for Cardiovascular Research
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Marija Zivkovic-Gojovic
Richard Pitman
Pragya Khurana
ICON
HealthEconomics.com
Disease Models
Ana Briones
Kent Scientific Corporation
American Physiological Society
European Council for Cardiovascular Research
Real-World Data (RWD)
Clinical Trials
Real-World Evidence (RWE)
Nitin Baliga
Thomas Brown
Syapse
HealthEconomics.com
Disease Models
In Vitro Assays
George Portugal
Harvard Bioscience, Inc.
American Physiological Society
European Council for Cardiovascular Research
Pharmacology
Cell Culture & Characterization
Toxicology
Martin Stahl
STEMCELL Technologies Inc.
Scientist.com

ポッドキャスト
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
7月 13, 2026
ポッドキャストを読む
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.





























.avif)








